← Human Trials & Peer-Reviewed Studies

Postprandial lipid, glucose, insulin, and cholecystokinin responses in men fed barley pasta enriched with beta-glucan

Plain-language guide to PMID 9925123 (1999): crossover randomized controlled trial study of Cholecystokinin (CCK) in 11 men.

Key Facts

PMID
9925123
Journal
The American journal of clinical nutrition
Year
1999
Study type
Randomized Controlled Trial
Authors
Bourdon I et al. (8 authors)
DOI
10.1093/ajcn/69.1.55

What This Study Did, in Plain Language

What Was Tested

This randomized controlled trial paper looks at Cholecystokinin (CCK).

The researchers investigated in 11 healthy men the response of insulin, glucose, cholecystokinin, and lipid to 2 test meals containing beta-glucan.

Why It Was Studied

Fiber regulates the rate and site of lipid and carbohydrate digestion and absorption and thus can modify the alimentary responses to a meal.

When fiber sources containing viscous polysaccharides are included in a meal, a slower rate of carbohydrate and lipid absorption will modify the alimentary hormone and lipid responses.

Who Took Part

According to the abstract, 11 men were involved.

PubMed indexes the participants as adults, men only.

How the Study Was Run

The design is described as randomized and crossover.

The men were allocated by chance, so the Cholecystokinin (CCK) group and the comparison group should start out alike.

Each person switched between Cholecystokinin (CCK) and the comparison at some point, usually with a gap in between.

The low-fiber meal contained pasta made with wheat flour.

What Was Measured

PubMed files the paper under topics including Analysis of Variance, Blood Glucose, Cholecystokinin, Dietary Fiber, Glucans, Hordeum and Insulin.

What This Means in Plain Language

The paper is a randomized and crossover study of Cholecystokinin (CCK) in 11 men.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

The abstract goes on to report its results in about 6 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 1999 (The American journal of clinical nutrition), a journal based in United States.

More context: the Cholecystokinin (CCK) compound page, all human trials.

Our Notes on the Compound

Cholecystokinin (CCK): A gut and brain peptide hormone that stimulates gallbladder contraction and signals fullness.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.